Every day our bodies are exposed to millions of pathogens, through contact, ingestion and the air we breathe in. The

Epidemiology is a field of science that studies the occurrence of disease in the general population in relationship to the

Over the past ten years, more and more pharma and biotech companies have turned to CROs, CMOs and CDMOs to

The US government has prioritised the development of next-generation vaccines targeted at anthrax that will provide improvements over the currently

Epigenetic discoveries and innovations may advance personalised medicine well beyond the realms of the genome, bringing hope for many people

Our environment is the niche of billions of bacteria, forming a real ecosystem. Some of these microorganisms are essential contributors

Pyrogens are substances that can induce shock, fever or death, with the most common type of pyrogen being the gram-negative

The Advantages of Using Respirable Engineered Spray-dried Dry Powder Inhaled drug products offer several advantages over other dosage forms, including

Dr Richard L Easton and Dr Andrew J Reason at BioPharmaSpec discuss how the development and production of any protein

The immune system has multiple mechanisms to detect and eradicate or neutralise pathogenic microorganisms. However, misguided immune response directed against

Advanced therapy medicinal products (ATMPs) represent a group of innovative pharmaceuticals that are increasingly gaining importance. It combines gene therapeutics,

Throughout the world, a key principle underpinning patent protection is that the scope of protection should depend on how the

Intelligent automation offers considerable potential for addressing the R&D productivity agenda, but how can life sciences firms exploit smart new

Over the last 10 years (2008–2017), the United States FDA approved a total of 320 new drugs. Of these, 249

Across the world, patients who once may have had little hope of survival are benefiting from the treatment efficacy and